BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/21/2023 7:31:20 AM | Browse: 169 | Download: 713
 |
Received |
|
2022-11-06 05:15 |
 |
Peer-Review Started |
|
2022-11-06 05:17 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-01-03 10:33 |
 |
Revised |
|
2023-01-27 11:50 |
 |
Second Decision |
|
2023-03-03 03:22 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-03-03 09:05 |
 |
Articles in Press |
|
2023-03-03 09:05 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-03-08 10:09 |
 |
Publish the Manuscript Online |
|
2023-03-21 06:10 |
ISSN |
1949-8462 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Retrospective Study |
Article Title |
Real-world five-year outcomes of FlexyRap® cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Preeti Vani, Malte Neuss, Nitish Garg, Raman Chawla, Vivek Tandon, Deepak Garg and Nilesh Parshottam |
Funding Agency and Grant Number |
|
Corresponding Author |
Preeti Vani, MSc, Researcher, Medical Division, Sahjanand Laser Technology Limited, A-8,G.I.D.C, Electronic Estate, Sec-25, Gandhinagar-382016, Gujarat, India., Gandhinagar 382016, India. preeti.vani@sltl.in |
Key Words |
Coronary artery disease; Drug-eluting stents; Percutaneous coronary intervention; Rapamycin; Sirolimus |
Core Tip |
Biodegradable polymer drug-eluting stents (BP-DES) have been proven to minimize restenosis and stent thrombosis. Our study evaluates the safety and effectiveness of FlexyRap® DES at the 5-year clinical response in real-world settings. The study proved the feasibility, safety, and efficacy of the FlexyRap® rapamycin-eluting stent for the treatment of de novo coronary artery disease, indicating low rates of events and stent thrombosis at 5-year follow-up. |
Publish Date |
2023-03-21 06:10 |
Citation |
Garg N, Chawla R, Tandon V, Garg D, Parshottam N, Vani P, Neuss M. Real-world five-year outcomes of FlexyRap® cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease. World J Cardiol 2023; 15(3): 84-94 |
URL |
https://www.wjgnet.com/1949-8462/full/v15/i3/84.htm |
DOI |
https://dx.doi.org/10.4330/wjc.v15.i3.84 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345